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Abstract: In clinical practice, a growing need exists for effective non-pharmacological   treatments 
of adult attention-deficit/hyperactivity disorder (ADHD). Here, we present the results of a pilot 
study of 10 adults with ADHD participating in short-term individual   cognitive-behavioral 
therapy (CBT), 9 adults participating in cognitive training (CT), and 10 controls. Self-report 
  questionnaires, independent evaluations, and computerized neurocognitive testing were   collected 
before and after the treatments to evaluate change. There were distinctive pre-hypotheses regard-
ing the treatments, and therefore the statistical comparisons were conducted in pairs: CBT vs 
control, CT vs control, and CBT vs CT. In a combined ADHD symptom score based on self-
reports, 6 participants in CBT, 2 in CT and 2 controls improved. Using independent evaluations, 
improvement was found in 7 of the CBT participants, 2 of CT   participants and 3 controls. There 
was no treatment-related improvement in cognitive performance. Thus, in the CBT group, some 
encouraging improvement was seen, although not as clearly as in   previous research with longer 
interventions. In the CT group, there was improvement in the trained tasks but no generalization 
of the improvement to the tasks of the neurocognitive testing, the   self-report questionnaires, 
or the independent evaluations. These preliminary results warrant further studies with more 
participants and with more elaborate cognitive testing.
Keywords: CBT, attention-deficit/hyperactivity disorder, cognitive testing, non-  pharmacological 
treatments
Introduction
The management of adult attention-deficit/hyperactivity disorder (ADHD) has 
been under increasing scientific and public debate in recent years, and the need for 
effective treatments is widely recognized. The most extensively studied treatments 
are pharmacological (for reviews, see, Dopheide & Pliszka1 and Tcheremissine 
et al2). Pharmacotherapy is thought to help with attention and executive functions 
deficits, but does not help the individual to develop compensatory strategies. There-
fore, in the last 10 years studies on psychological interventions have also emerged. 
Several group interventions3–9 have yielded promising results in treating adults with 
ADHD. Only a few studies on individual cognitive-behavioral therapy (CBT) have 
been published.10–12 Wilens et al10 reported the effectiveness of 10–103 sessions of 
individual cognitive therapy, but there was no control group and the study was con-
ducted as a chart review. Safren et al12 randomized their participants to continued 
pharmacotherapy alone or a combined pharmacotherapy plus a CBT treatment that 
they had developed. The combined treatment was found to be associated with bet-
ter improvement in self-reported symptoms and independent evaluators’ ratings as Neuropsychiatric Disease and Treatment 2010:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
444
Virta et al
compared to pharmacotherapy alone. Rostain and Ramsay11 
combined pharmacotherapy with 16 sessions in a period of 
six months of CBT modified to treat adults with ADHD, but 
they had no control group. They found that the treatment was 
associated with improvements in the measures used, but as 
they state, their study design did not allow conclusions about 
the relative contribution of CBT or pharmacotherapy.
Psychosocial treatments usually focus on compensatory 
strategies, altering dysfunctional thoughts and attitudes, and 
improving metacognition, but they do not directly target the 
core cognitive symptoms of ADHD, such as problems of 
attention or working memory. In children, some results have 
been reported on the effectiveness of cognitive training (CT) 
in treating these deficits.13–16 These studies are, however, only 
case reports or include a small number of patients. There 
is some evidence that healthy adults may also benefit from 
computerized working memory training.13,17 In adults with 
ADHD, attention-switching impairment has been shown to 
ameliorate with short-term computerized training.18 To the 
best of our knowledge, no other studies on CT in adults with 
ADHD have been reported before.
The aim of this study was to preliminary examine the 
feasibility and efficacy of short-term individual CBT and CT 
in adults with ADHD and their impact on ADHD   symptoms, 
mood, quality of life, and cognitive performance. We 
  hypothesized that (i) compared to the controls, the partici-
pants in the CBT group would benefit from the treatment, 
although this may not be as clear as in previously published 
studies because of the shorter duration of the therapy, and 
(ii) the participants in the CT group would improve their 
performance in trained tasks, and this improvement would 
at least partly generalize to other measures of the same 
cognitive functions. In addition, we hypothesized that the 
participants in the CT group would benefit from the treatment 
as compared to the control group, and this is seen partly in 
their cognitive performance but not as clearly in their self-
reports. Although children with ADHD have been shown to 
benefit from CT, the adult brain has less plasticity, and thus 
the treatment gain is hypothesized to be smaller in adults, 
and (iii) the participants in CBT would benefit more than the 
participants in CT.
Method
Participants
The participants were recruited by announcements placed in 
an ADHD magazine and an adult ADHD internet discussion 
forum, and by informing local physicians and clinics special-
ized in treating ADHD in adults. The inclusion criteria were 
as follows: (i) 18–49 years of age; (ii) ADHD diagnosis made 
by a physician; (iii) no diagnosis of psychosis, severe depres-
sion or paranoia; (iv) deficits of attention, executive functions 
or working memory identified in a   neuropsychological evalu-
ation that had been made earlier; (v) no current alcohol depen-
dency or drug use; (vi) not receiving a   disability pension; 
(vii) no participation in our previous group rehabilitation 
study; (viii) currently not undergoing any other psychologi-
cal rehabilitation; and (ix) no medication or medication that 
has been stable for at least three months.
In total, 71 interested candidates contacted the researchers 
and were briefly telephone-screened for the inclusion criteria. 
Of these, 17 individuals were excluded for not meeting all 
the inclusion criteria: 11 for having no neuropsychological 
examination and six for reasons such as diagnosis of psy-
chosis, severe depression or paranoia, older age, retired, or 
current psychological rehabilitation. If the medication was 
not stabilized, the candidate was put on a waiting list until 
this criterion was met.
A total of 54 potential candidates were invited to an 
interview with a psychologist. The aim of the interview was 
to screen for the inclusion criteria more closely, to explain 
the study protocol in more detail and to obtain the informed 
consent of each candidate before recruitment. Medical 
records were evaluated to ensure the diagnosis of ADHD and 
the accurate fulfillment of inclusion criteria 3 and 4. Seven 
candidates withdrew from the study before the interview or 
did not attend the interview. At the end of the interview, the 
candidates filled in a questionnaire of detailed background 
information and the Wender Utah Rating Scale (WURS).19 
On the basis of the collected information, the psychologists 
(AS, MV) verified that the candidate met both the DSM IV 
criteria for ADHD20 and the criteria for the study. Only one 
candidate was excluded at this stage because the required 
neuropsychological deficits were lacking. Thus there were 
46 participants who were randomly assigned to one of four 
groups: hypnotherapy, individual CBT, computerized CT, or 
the control group. Four of participants accepted for the study 
withdrew their participation and three quit during the study 
(two in the CBT and one in the CT group). Thus there were 
a total of 39 participants. Here we present the results for the 
CBT, CT and control groups; the results of the hypnotherapy 
group are published elsewhere.21
There were 10 participants in the CBT and control groups, 
and nine in the CT group. The demographic data of the groups 
are presented in Table 1. Five of the 10 participants of the 
CBT group were receiving medication for ADHD, and all of 
them took methylphenidate. One participant ceased taking Neuropsychiatric Disease and Treatment 2010:6 submit your manuscript | www.dovepress.com
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her medication during the rehabilitation, and one added a 
short-acting methylphenidate Ritalin to the previous long-
acting methylphenidate Concerta. Five of the nine partici-
pants of the CT group were receiving medication for ADHD: 
four of them took methylphenidate and one modafinil. One 
participant ceased taking her methylphenidate medication 
and one changed from Concerta to Equasym, which is a 
methylphenidate with shorter duration, during the reha-
bilitation. Seven of the 10 participants of the control group 
received medication for ADHD: five took methylphenidate, 
one received modafinil, and one received atomoxetine (which 
was changed to methylphenidate during the study).
The three groups did not differ, as analyzed by an analysis 
of variance or Chi-Square test, in age, gender, education, work 
status, WURS score, severity of ADHD (measured by Clini-
cal Global Impressions, CGI at the baseline) or number of 
participants having psychiatric comorbidity (all Ps . 0.05).
None of the participants in the control group received any 
treatment during the follow-up period. After the follow-up 
period, eight of them participated in group rehabilitation7 and 
the remaining two in individual rehabilitation.
The study was approved by the Ethics Committee of 
Helsinki University Central Hospital, Finland and performed 
in accordance with the ethical standards laid down in the 
1964 Declaration of Helsinki. All participants gave their 
written informed consent prior to participating in the study. 
Participation was free of charge.
cognitive-behavioral therapy
The themes of the treatment sessions were selected to 
cover the main symptoms set out in the DSM-IV diagnostic 
  criteria20 and by Brown.22,23
The CBT consisted of 10 weekly sessions led by a 
  psychologist experienced in ADHD and training in CBT 
(AS). The themes and contents of the sessions are presented 
in Table 2. The first six sessions and the last session had 
same content for all the participants, although allowing for 
some individual modification. Sessions seven, eight and nine 
were individually tailored. A limit was set at two sessions 
per theme. For example, it was possible to have self-esteem 
(session six) as one of the individually chosen sessions or 
impulsivity (not in sessions one to six) in two individual 
sessions. The psychologist followed a written manual.24 
The sessions were semi-structured so as to allow individual 
treatment. The most important points and tasks at hand were 
illustrated using printed material and a whiteboard, and at the 
end of the session, the material discussed was distributed to 
the participants in written form. In addition, the participants 
were given homework related to the theme discussed. Each 
session followed the same procedure: discussion of the 
  previous homework and theme, introduction and discussion 
Table 1 characteristics of the participants at the beginning of 
the treatment
CBT CT Control
Participants (n) 10 9 10
Age: mean (range) 38.2 (25–49) 32.0 (21–44) 34.0 (22–49)
gender: man/woman 3/7 7/2 4/6
education:  
compulsory/additionala
1/9 2/7 1/9
Work/study: yes/nob 4/6 7/2 7/3
ADhD medication (n) 5 5 7
Antidepressive  
medication (n)
2 1 2
Any psychiatric  
comorbidity (n)
7 4 3
  Depression (n) 6 1 3
  Anxiety (n) 0 1 2
  Personality disorder (n) 1 3 0
Wurs score: mean (sD) 53.1 (12.3) 61.2 (11.2) 51.0 (15.3)
severity of ADhD (cgi) 
  Mean (sD)
3.8 (0.8) 3.4 (0.5) 3.4 (0.5)
Notes: acompulsory = the participant had completed only lower secondary education 
(ie, Finnish compulsory education); bWork/study yes = the participant was working   
(at least in a half-time job) or studying.
Abbreviations: cBT, cognitive behavioral therapy; cT, cognitive training. 
Table  2  content  of  the  semi-structured  cognitive-behavioral 
therapy (cBT)
Session 1: Goals and symptoms of ADHD
  goals and overview of the therapy
  symptoms of AD/hD
Session 2: Attention
  Different aspects of attention
  AD/HD and difficulties in attention and attention-related functions
  Techniques for relieving attentional problems
Session 3: Motivation and initiation of activities
  Motivation
  AD/HD and difficulties in getting things started
  Techniques for improving motivation and initiation
Session 4: Organization and planning
  AD/HD and difficulties in organizing and planning
  Techniques for organizing time schedules and environment
Session 5: Stress management and relaxation
  stress and stress management
  relaxation exercise
Session 6: Self-Esteem
  Negative beliefs and self-esteem
  Techniques for improving self-esteem and reformulating negative beliefs
Sessions 7 to 9: Individually chosen topics
      For example, memory techniques, managing impulsivity, anger 
management or an extra session on some of the previous themes 2–6
Session 10: The continuation of the process,  
ending the rehabilitation
  reviewing of the main points
  Future challenges and dealing with relapses Neuropsychiatric Disease and Treatment 2010:6 submit your manuscript | www.dovepress.com
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of the new theme, and assignment of the new homework and 
distribution of the written material. The duration of a session 
was approximately 60 minutes.
cognitive training
A CT program was developed to include the training of 
  attention, executive functions, and working memory as widely 
as possible within one hour of   computerized,   systematic 
  training. The tasks are presented in Table 3. The tasks involved 
domains of attention as follows:   focus-executive (tasks 2 
and 7), sustain (1A-D, 4A), encode (5), and shift (6),25 and 
focused (all tasks), sustained (1A-D, 2, 3, 4A-B, 5, 9), selec-
tive (1E), alternating (6), and divided (4C, 7, 8) attention.26,27 
Some of the tasks required executive functions (task 1E: 
response inhibition; Tasks 4C and 6: cognitive flexibility) 
and working memory (3, 5, 9).
Table 3 content of the cognitive training (cT)
Task 1: Continuous performance tasks (CPT)
1A-1c: Letters are presented consecutively on the screen for 3 minutes. in 1A, the participant has to press a button when the target letter appears. 
in 1B, he/she has to press a button when either of the two target letters appears. in 1c, the participant has to press a button when the target letter 
appears after a predetermined cue letter. 1D: Letters are presented via loud speaker for 3 minutes, and the participant has to press a button each 
time the target letter is heard. 1e: Letters are presented on the screen and via loud speaker for 3 minutes. The participant has to press a button 
when the target letter appears on the screen and simultaneously ignore distracting letters he/she hears from the loud speaker. 
Adjustment of the difficulty level: When a participant succeeds in performing at a predetermined level, the time interval between the onsets of the 
stimuli is shortened.
Task 2: Digit search
A 20 × 20 matrix of single digits is presented on the screen. The participant has to search for all the target digits as quickly as possible and 
click on them with a mouse. There are three different kinds of tasks: a search for two targets, three targets or three targets with an extra rule 
(a predetermined cue digit has to precede the third target digit).
Adjustment of the difficulty level: When a participant succeeds at the simplest task at a predetermined level, a more difficult task is then presented.
Task 3: Circle-letter sequences
circles are presented on the screen. They start to turn red in random order, and a letter appears shortly under each red circle. After the presentation 
of the whole sequence, the participant is asked to remember which letter appeared below which circle in random order. each sequence length is 
presented three times, and if a participant gets two or three of them correct, a longer sequence is presented.
Adjustment of the difficulty level: Circle-letter sequences are lengthened according to the participant’s performance.
Task 4: CPT and a simultaneous task
4A: Colored geometric figures are presented on the screen one at a time for 3 minutes. The participant has to press a button when the target figure 
(of the correct shape and color) appears. 4B: simple addition problems are presented on the screen for 3 minutes. The participant has to press a 
button when the calculation is incorrect. 4c: The participant performs tasks 4A and 4B simultaneously for 3 minutes.
Adjustment of the difficulty level: When a participant succeeds in performing at a predetermined level, the time interval between the onsets of the 
stimuli is shortened.
Task 5: Digit arrangement
simple digits are presented in random order via loud speaker. The participant has to arrange them in the right order (eg, 1-5-0-1-7 is 0-1-1-5-7). each 
sequence length is presented twice, and if a participant gets either one of them correct, a longer sequence is presented.
Adjustment of the difficulty level: Digit sequences are lengthened according to the participant’s performance.
Task 6: Alternating rules
groups of alternating colored letters are presented on the screen together with alternating rules for the task (eg, press a button when there is a 
green A/at least three C’s/not a blue K). The participant presses the button according to the rules for 3 minutes.
Adjustment of the difficulty level: Stimuli are presented more quickly when participant succeeds in performing at a predetermined level. At the easiest 
level, a beep sound indicates when a rule is changed.
Task 7: Digit-letter search
A 20 × 20 matrix of single digits is presented on the screen. The participant has to search for the target digits as quickly as possible and click on them 
with a mouse. simultaneously, he/she hears letters and has to press a button each time the target letter is heard.
Adjustment of the difficulty level: When a participant succeeds in performing at a predetermined level, the time interval between the onsets of the 
stimuli is shortened.
Task 8: Counting while reading
A text is presented on the screen. The participant reads it aloud and simultaneously counts silently (mentally) how many target letters are imbedded 
in the text.
Adjustment of the difficulty level: The text is lengthened when the participant succeeds in performing at a predetermined level. At the easiest level, 
the target letters are presented in bold.
Task 9: Circle sequences
9A: A 5 × 5 matrix of circles is presented on the screen. some of the circles turn red in random order. After the presentation, the participant has to 
click on the circles with a mouse in the same order. 9B: The task is the same as 9A except that the circles are to be clicked in reverse order.
Adjustment of the difficulty level: The circle sequence is lengthened according to the participant’s performance.Neuropsychiatric Disease and Treatment 2010:6 submit your manuscript | www.dovepress.com
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The CT consisted of 20 sessions taking place twice a 
week and led by a psychologist (AS). Tasks 1A, B and C 
were practiced only in every third session. All the other tasks 
were completed in every session. Each participant received 
feedback on the screen immediately after each task, and the 
feedback was discussed with the psychologist. There were 
several difficulty levels in the tasks – at least three in each, 
and in most of the tasks at least six – and the tasks were 
adjusted to a suitable level on a trial-by-trial basis (Table 3). 
The duration of a session was approximately 60 minutes.
Because of the large number of tasks and variables, 
the participants’ performance change is only presented for 
four tasks in the Results section, namely for tasks 3, 5, 4C 
and 7. In tasks 3 and 5, the length of the longest correctly 
remembered/arranged sequence in every session is taken as 
the result. In tasks 4 and 7, the difficulty level used at each 
session is the result. In task 7, there were seven difficulty 
levels in which the visual stimuli were always similar, but 
the presentation rate of the auditory stimuli varied – that is, 
the time elapsed from the onset of the previous letter to the 
onset of the next letter was either 2200, 1900, 1600, 1300, 
1100, 900 or 850 ms. At the first session, all the participants 
started at level three (1600 ms). If the participant’s responses 
were more than 90% correct and he or she made less than 
five erroneous responses in both tasks, level four (1300 ms) 
was presented at the next session. If the participant got less 
than 70% correct or made more than 10 errors, the easier 
level two (1900 ms) was presented at the next session. In task 
4, the same rules were applied, and the time elapsed from 
the onset of the previous item to the onset of the next item 
was 4000, 3500, 3000, 2500, 2000, 1500, 1200, 1100, and 
1000 ms (9 levels), starting at level three (3000ms).
Outcome measures
As outcome measures we used self-report questionnaires, 
independent evaluations, and computerized neurocogni-
tive testing. For the treatment groups, data were collected 
before the treatment (T1) and after the treatment (T2). Data 
obtained from the control group were also collected on two 
occasions. T2 measurements were scheduled to be taken 
about 11 or 12 weeks after T1 to correspond to the time in 
the treatment group. The mean time elapsed between T1 and 
T2 (the questionnaires and the neurocognitive testing) was 
82 days (range 63–112) for the CBT group, 94 days (range 
56–115) for the CT group, and 81 days (range 69–91) for 
the control group. The T1 questionnaires and testing were 
completed 0–12 days before the first CBT or CT sessions, and 
the T2 measures 0–9 days after the last session. Independent 
evaluations were collected before T1 and after T2, within 
two weeks of the collection of self-report questionnaires and 
neurocognitive testing (with one exception of three weeks). 
The independent evaluator was a clinical psychologist (MA) 
who was blind to the actual study group of participants. The 
measures used were:
Brown Attention Deficit Disorder Scale – Adult 
Version (BADDs)28
The BADDS is a 40-item inventory of which we used the 
self-report version. From BADDS, a total score and scores 
of the five subdomains of activation, attention, effort, affect, 
and memory were derived. Higher scores indicate a greater 
impairment.
World Health Organization’s Adult ADHD  
self-report scale (Asrs)29
The ASRS is an 18-item scale reflecting the DSM-IV criteria 
modified for adults. We used both self-report and independent 
evaluator measurements. We report the total score in which 
the higher the scores, the greater the impairment.
symptom check List (scL-90)30
The SCL-90 is a 90-item self-report scale for the measure-
ment of psychiatric symptoms. Several subscales can be 
calculated, but we used the total score. Moreover, a 16-item 
sum score (SCL-16) reflecting the characteristics prominent 
in ADHD3 was calculated from the SCL-90. The higher the 
scores, the greater were the symptoms.
Beck Depression inventory, second edition (BDi-ii)31
The BDI II is a 21-item scale that evaluates current self-
reported symptoms of depression. Higher scores reflect 
greater problems.
Quality of Life enjoyment and satisfaction 
Questionnaire (Q-Les-Q)32
The Q-LES-Q is a 93-item self-report scale, from which 
91 items can be grouped into eight subscales that indicate 
satisfaction with physical health, subjective feelings, work, 
household duties, school, leisure activities, social relation-
ships, and general activities. We combined the work and 
school subscales into a work/study subscale. When a par-
ticipant gave both scores, the main score was used (ie, if 
the participant was working full time and also taking some 
educational courses, then the work score was used). Higher 
scores indicate greater enjoyment or satisfaction. The scores 
are reported as a percentage of the maximum score.Neuropsychiatric Disease and Treatment 2010:6 submit your manuscript | www.dovepress.com
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clinical global impressions (cgi)33
CGI was completed by the independent evaluator. At T1, the 
severity of ADHD was evaluated according to CGI, which 
is a single 7-point rating scale of functioning varying from 
1 = normal, not at all ill, to 7 = among the most extremely 
ill patients. At T2, global improvement was assessed using 
a 7-point scale varying from 1 = very much improved, to 
7 = very much worse (4 = no change). Classes 1 to 3 were 
combined to represent improvement, and classes 4 to 7 were 
combined to represent non-improvement.
cNs Vital signs (cNsVs)34,35
CNSVS is a computerized neurocognitive test battery com-
prising seven neuropsychological tests: verbal memory, 
visual memory, finger tapping, symbol-digit coding, the 
Stroop test, the shifting attention test, and the continuous 
performance test. Five standardized domains were obtained 
from the tests: memory, psychomotor speed, reaction time, 
cognitive flexibility, and complex attention. In addition, we 
used the neurocognition index, which is the mean of the 
domains. A detailed description of the tests of CNSVS has 
been given by Gualtieri and Johnson.35,36
In addition, the CBT and CT participants evaluated the 
benefit of the rehabilitation at T2 using a five-option rating 
scale of no benefit, minor benefit, moderate benefit, clear 
benefit, and substantial benefit.
statistical analyses
The individual missing values on the questionnaires were 
substituted with the respondent’s mean score. However, no 
replacements were made in the Q-LES-Q as the scores were 
calculated as a percentage of the maximum score.
The distribution properties of the variables were inspected 
visually and with Shapiro-Wilk tests. Parametric tests were 
chosen for the statistical analyses. Since we had clear pre-
hypotheses to be tested, comparisons were made for three 
different pairings: the CBT group vs the control group, the 
CT group vs the control group, and the CBT group vs the CT 
group. A two-way mixed ANOVA with one between factor, 
group, and one within factor, time (T1 vs T2) was performed. 
The effect sizes were quantified by partial eta squared ηp
2. 
When the ANOVA was significant or almost significant 
(P , 0.10) and the effect size large (ηp
2 . 0.138), paired 
t-tests were also performed for all groups separately. Changes 
in CGI were analyzed using the Chi-square test (χ2).
Results
The mean scores of the self-report and computerized 
  neurocognitive test battery measures for the CBT, CT and 
control groups are presented in Table 4. The treatment lasted 
for 10.5 weeks (range 9–15 weeks) for the CBT and 12.2 
weeks (range 7.6–15.3 weeks) for the CT.
cognitive behavioral therapy group 
versus controls
To compare the CBT group with the control group, a two-
way ANOVA with one between-factor, group (CBT vs 
control), and one within-factor, time (T1 vs T2), was per-
formed. There was a significant Time × Group interaction 
in BADDS attention [F(1,18) = 7.24, P , 0.05, ηp
2 = 0.29], 
memory [F(1,18) = 6.32, P , 0.05, ηp
2 = 0.26] and total 
scores [F(1,18) = 6.32, P , 0.05, ηp
2 = 0.26]. Moreover, an 
almost significant interaction was found for the Q-LES-Q 
work/study subscale [F(1,11) = 4.28, P = 0.06, ηp
2 = 0.28]. As 
seen in Table 4, a decrease in symptoms takes place mainly in 
participants of the CBT group. No other statistically signifi-
cant interactions were found in the self-report questionnaires 
(all Ps . 0.10). There were also no statistically significant 
interactions in the standardized domains and neurocognition 
index for CNSVS (all Ps . 0.10).
In the control group, there was no difference between T1 
and T2 in any measure (all Ps . 0.05) in paired t-tests. In 
contrast, there was a significant decrease of symptoms between 
T1 and T2 in the CBT group in BADDS attention [t(9) = 4.35, 
P , 0.01, ηp
2 = 0.68], memory [t(9) = 2.78, P , 0.05, ηp
2 = 0.46] 
and total scores [t(9) = 3.96, P , 0.01, ηp
2 = 0.64].
The participants were classified into two groups according 
to their individual improvement or nonimprovement during 
the study. A participant was defined as “improved” when 
he or she had reduced self-reported symptoms in all ratings 
of ADHD symptoms, namely the BADDS total score, the 
SCL-16, and the ASRS. In cases of either symptom eleva-
tion or no change in any of the measures, the participant was 
classified as “not improved”. Six of the 10 participants (60%) 
in the CBT group were improved compared with two of the 
ten (20%) in the control group. The difference was almost 
statistically significant (χ2 = 3.33, df = 1, P = 0.07).
According to the independent evaluators’ CGI ratings, 
seven of the 10 (70%) participants in the CBT group and three 
of the 10 individuals (30%) in the control group improved 
from T1 to T2. The difference was almost statistically sig-
nificant (χ2 = 3.20, df = 1, P = 0.07). For the independent 
evaluator-rated ASRS, no statistically significant interaction 
was found [F(1,18) = 1.67, P = ns, ηp
2 = 0.09].
In the participants’ self-evaluations of the treatment 
benefit, nine of the ten CBT participants reported at least a 
clear benefit.Neuropsychiatric Disease and Treatment 2010:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
449
cBT and cognitive training for adults with ADhD
cognitive training group versus controls
The participants’ performance in the trained tasks was analyzed 
to find out whether there was task-specific   improvement related 
to the rehabilitation. In task 3, the participants were able to 
remember correctly a sequence of 3.22 (SD 1.48) items in the 
first session and 5.44 (1.94) in the last   session. This difference 
is statistically significant [t(8) = 4.26, P , 0.01, ηp
2 = 0.66]. In 
task 5, the participants were able to arrange correctly a sequence 
of 6.56 (SD 1.01) items in the first session and 8.33 (3.40) in 
the last session, reaching statistical significance [t(8) = 2.16, 
P , 0.05, ηp
2 = 0.44]. The rising learning curve of participants’ 
performance in tasks 4C and 7 is presented in Figure 1.
In the self-report questionnaires, when analyzing the CT 
and control groups with an ANOVA, there was an almost 
significant Time × Group interaction between T1 and T2 in 
BADDS affect [F(1,17) = 3.23, P = 0.09, ηp
2 = 0.16]. In a 
paired t-test, the CT group had a significant decrease in symp-
toms between T1 and T2 [t(8) = 3.18, P , 0.05, ηp
2 = 0.56] 
in BADDS affect (see Table 4). There were no statistically 
significant interactions in other self-report questionnaires 
(all Ps . 0.10). No statistically significant interactions were 
found in measures of CNSVS (all Ps . 0.10).
Two of the nine participants (22%) in the CT group were 
classified as improved compared with two of the ten (20%) in 
the control group. Thus, the groups did not differ (χ2 = 0.01, 
df = 1, P = ns).
According to the independent evaluators’ CGI ratings, 
two of the nine (22%) participants in the CT group and three 
of the 10 individuals (30%) in the control group improved 
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Figure 1 Level of performance for tasks 4c and 7 during the rehabilitation in every 
session.
Table 4 Mean (standard deviation) scores for the participants’ self-ratings and computerized neurocognitive test battery at T1 (before 
treatment) and T2 (after treatment)
CBT CTa Controls
T1 T2 T1 T2 T1 T2
BADDs
  Activation 20.2 (2.0) 17.5 (4.5) 17.6 (3.7) 15.0 (4.8) 17.2 (6.1) 16.8 (6.1)
  Attention 22.3 (3.3) 18.3 (5.0) 17.8 (3.1) 16.2 (5.2) 19.3 (3.3) 19.1 (3.2)
  effort 18.4 (4.3) 15.6 (4.4) 16.8 (4.9) 13.9 (6.2) 15.6 (5.9) 14.4 (6.1)
  Affect 11.6 (2.2) 9.6 (2.8) 10.0 (3.1) 6.9 (4.2) 9.1 (3.1) 8.7 (4.4)
  Memory 12.3 (4.5) 10.5 (5.0) 9.7 (4.6) 9.2 (3.0) 10.4 (4.4) 11.0 (4.1)
  Total 84.8 (12.8) 71.5 (18.6) 71.8 (13.5) 61.2 (17.8) 71.6 (16.3) 70.0 (14.2)
BDi iia 13.6 (5.6) 9.0 (8.3) 6.4 (5.5) 4.8 (5.8) 11.0 (7.7) 9.5 (11.6)
scL-90 95.4 (21.2) 81.9 (27.7) 67.6 (31.4) 68.0 (34.0) 94.1 (37.8) 89.7 (48.0)
scL-16 31.0 (7.4) 25.2 (5.3) 20.9 (8.1) 22.9 (9.2) 31.5 (11.9) 30.2 (11.5)
Asrs 50.7 (10.7) 45.4 (11.7) 45.7 (6.7) 41.2 (4.9) 50.8 (7.7) 47.8 (12.0)
Q-Les-Qc 
  general 55.7 (8.6) 60.9 (14.5) 60.3 (12.6) 65.2 (14.4) 54.4 (11.7) 59.2 (21.0)
  Work/studyb 58.7 (23.9) 72.7 (15.2) 66.1 (15.8) 67.5 (19.0) 73.3 (8.2) 59.0 (25.6)
cNsVs
  Neurocognitive index 85.4 (15.1) 97.6 (9.2) 94.3 (9.5) 97.6 (11.9) 97.1 (13.0) 102.5 (10.1)
  Memory 92.9 (19.8) 102.1 (12.8) 89.0 (16.3) 91.4 (21.2) 104.7 (15.4) 111.6 (12.4)
  Psychomotor speed 80.3 (15.9) 81.1 (13.8) 94.0 (16.3) 98.8 (6.6) 90.2 (14.2) 90.8 (16.0)
  reaction time 82.9 (24.3) 94.9 (14.0) 90.4 (12.5) 94.6 (14.8) 96.2 (10.7) 99.3 (12.3)
  Flexibility 82.9 (21.5) 104.9 (15.5) 98.7 (14.3) 104.1 (17.1) 96.1 (24.7) 106.3 (18.4)
  Attention 88.0 (19.3) 105.9 (8.9) 98.7 (16.6) 98.1 (15.8) 98.0 (17.6) 104.4 (16.9)
Notes: N = 10 except; aN = 9 in the cognitive training (cT) group; bA participant was included only if scores were available for both T1 and T2. in the cognitive behavioral 
therapy (cBT) group N = 7, in the cT group N = 8 and in the control group N = 6; cAll subscales of the Q-LES-Q were analysed, but no statistically significant results were 
found. Only the results of the general and combined work/study subscale are presented here.Neuropsychiatric Disease and Treatment 2010:6 submit your manuscript | www.dovepress.com
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from T1 to T2. This difference was not statistically significant 
(χ2 = 0.15, df = 1, P = ns). Moreover, there were no statisti-
cally significant interactions for the independent evaluator-
rated ASRS [F(1,18) = 0.55, P = ns, ηp
2 = 0.03].
In the participants’ self-evaluations of the treatment 
benefit, four of the nine CT participants reported at least a 
clear benefit.
cognitive-behavioral therapy versus 
cognitive training
There was an almost significant Time × Group interaction 
of symptoms between T1 and T2 in BADDS attention 
[F(1,17) = 3.12, P = 0.09, ηp
2 = 0.15] and the SCL-16 
[F(1,17) = 4.20, P = 0.06, ηp
2 = 0.20], suggesting more 
improvement in the CBT group (see Table 4). No other sta-
tistically significant interactions were found in the self-report 
measures. Thus, the amelioration of symptoms in the two 
groups did not statistically differ. No statistically significant 
interactions were found for CNSVS either (all Ps . 0.10).
As previously mentioned, six of the 10 participants (60%) 
in the CBT group were classified as improved compared with 
two of the nine (20%) in the CT group. This difference was 
almost statistically significant (χ2 = 2.77, df = 1, P = 0.10).
According to the independent evaluators’ CGI ratings, 
seven of the 10 (70%) participants in the CBT group and 
two of the nine individuals (22%) in the CT group improved 
from T1 to T2. This difference was statistically significant 
(χ2 = 4.34, df = 1, P , 0.05). No statistically significant 
interaction for the independent evaluator-rated ASRS was 
found [F(1,17) = 2.52, P = ns, ηp
2 = 0.13].
Discussion
The aim of the present pilot study was to examine the poten-
tial feasibility and efficacy of short-term CBT and CT in 
treating adults with ADHD. The influence of the treatments 
on ADHD symptoms, mood, quality of life, and cognitive 
performance were evaluated. Both treatments were found to 
be quite acceptable and tolerable to the participants: only two 
participants in the CBT group and one in the CT group quit 
during the rehabilitation. Since there were three distinctive 
pre-hypotheses, the CBT group was compared to the control 
group, the CT group to the control group, and the CBT group 
to the CT group.
short-term cognitive-behavioral therapy
The self-reported symptoms of participants in the CBT group 
decreased significantly (or almost significantly with large 
effect sizes) in BADDS attention, memory, and total scores, 
and on the Q-LES-Q work/study subscale, as   compared to 
the control group. When individual percentages of change 
were investigated, six of the 10 participants in the CBT group 
had improved compared with two of the 10 in the control 
group. According to the independent evaluator’s CGI ratings, 
seven of the 10 participants in the CBT group and three of 
the 10 in the control group, improved from T1 to T2. There 
were no statistically significant interactions in the standard-
ized domains and neurocognition index of CNSVS. The 
participants’ self-evaluations regarding the usefulness of the 
program were quite high; nine of the 10 CBT participants 
reported at least a clear benefit.
The improvement found in self-report questionnaires, 
self-evaluations, and independent evaluator’s ratings is 
consistent with our pre-hypothesis and previous studies 
of individual CBT in adult ADHD.10–12 It is, nevertheless, 
somewhat difficult to compare the present and previous 
studies since they differ in inclusion criteria, study design, 
and measures used. For example, our participants seemed to 
benefit less than the participants in Rostain and Ramsay’s11 
study, where the BADDS total scores decreased from 70.5 
to 49.9 (ours decreased from 84.8 to 71.5). However, their 
participants received a combined treatment (CBT and 
  medication), whereas the participants of our study were either 
non-medicated or stably medicated before the   treatment. 
The treatment duration in Rostain and Ramsay’s study was 
16 sessions over 6 months as compared to the 10 sessions 
and 2.5 months of the present study. Since ADHD is a 
developmental disorder with long-lasting and often pervasive 
problems, it is reasonable that CBT of longer duration may 
be needed to develop and establish adaptive coping skills. 
However, some encouraging improvement was seen with our 
short-term CBT, although not as clearly as in previous studies 
with longer interventions. We hypothesize that this kind of 
short intervention may be useful right after a diagnosis or 
for milder cases, and longer-term treatments could be used 
for those with more pervasive problems.
cognitive training
A training benefit was clearly seen in the trained tasks, where 
most of the participants improved their performance markedly. 
However, the benefit was not seen in CNSVS or in most of 
the self-report questionnaires. Only a decrease in the BADDS 
affect score was observed (almost statistically significant, large 
effect size). In addition, no improvement was found in indi-
vidual percentages of change or independent evaluations.
The improvement in trained tasks is in line with our 
pre-hypothesis. However, it was also hypothesized that this Neuropsychiatric Disease and Treatment 2010:6 submit your manuscript | www.dovepress.com
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task-specific improvement would generalize at least in some 
extent to cognitive measures and perhaps not as strongly to 
the self-report questionnaires. Against our expectations, this 
was not found. In a previous study of working memory train-
ing with nonmedicated ADHD children, learning was found 
to generalize to nontrained working memory tasks, other 
nontrained measures of executive function, and parent ratings, 
but not to teacher ratings.14 The same study group has also 
found that working memory training improves   performance in 
healthy adults and that this improvement also transfers to other 
measures.13,17 Also short-term attention-switching training has 
been shown to transfer to new tasks of attention-switching in 
adults with ADHD.18 Thus, our findings also disagree with the 
previous studies. However, this may not necessarily mean that 
adults with ADHD do not benefit from this type of CT. It is 
possible that CNSVS, which was used as the cognitive measure 
was too easy for the participants (see the general discussion 
section), or that the CNSVS tasks did not measure the same 
components of attention and executive functions that were 
trained. The intensity of training might also be influential. In 
addition, the improvement seen in BADDS affect is intriguing. 
This may be just a random result due to the small sample size, 
or it may reflect the training of impulse control.
To the best of our knowledge, this is the first study 
examining the effects of CT in adults with ADHD. Clearly, 
the possibilities of CT for adult ADHD need to be studied 
more in the future.
comparison of the two treatments
The two treatments studied here were equal in length, but 
  differed in intensity: CBT took place once a week, whereas CT 
took place twice a week. The self-reported symptoms of CBT 
participants decreased almost significantly more (with a large 
effect size) in BADDS attention and the SCL-16 as compared 
to the CT participants. No statistically   significant differences 
were found in CNSVS. According to the individual percent-
ages of change (six of the 10 in the CBT group and two of 
the nine in the CT group were classified as improved) and the 
independent evaluators’ CGI ratings (seven of the 10 in the 
CBT group and two of the nine in the CT group improved), 
the participants in the CBT group benefited more.
Thus, at the general level, even our very short-term CBT 
seemed to be more effective than CT with more sessions. 
This is in line with our pre-hypothesis. However, at the level 
of individual measures, the evidence is limited. Rostain and 
Ramsay have argued that pharmacotherapy is a bottom-up 
treatment targeting the core symptoms of ADHD, and that 
CBT represents a top-down approach.11 We assume that CT 
is mainly a bottom-up treatment, but since the participants 
received feedback from the tasks, and some of them were 
active in developing and testing their own strategies, a top-
down approach was also embedded in it. However, it seems 
that CT is not as beneficial as the top-down CBT.
general discussion
More than half of our participants were medicated at the 
beginning of the treatment (five of the 10 in the CBT group, 
five of the nine in the CT group, and seven of the 10 in the 
control group). Their medication was required to be stabilized 
for three months before the treatment, and there were only 
minor changes in medication during the treatment. It can be 
assumed that the positive effects of pharmacotherapy were 
already obtained before entering the study, and therefore, 
the treatment benefits were not related to medication. Safren 
et al12 found that better treatment results are gained when 
adding psychosocial treatment to pharmacotherapy. This is 
in line with our results where CBT seemed to be effective 
for already medicated participants.
Previously, only two psychosocial intervention   studies 
of adult ADHD have used cognitive functioning as an 
outcome measure.3,8 In a study on mindfulness training,8 
improvement in tasks of attention and cognitive inhibition 
was found. In a pilot study using a structured skills training 
program in a group setting,3 neuropsychological testing was 
used at baseline and following treatment, and some tendency 
towards improvement was found. However, a practice effect 
cannot be ruled out in either study since neither had a control 
group,8 or when present, the control group did not undergo 
  neuropsychological testing.3 In our study, no treatment-related 
improvement was found in cognitive functioning as measured 
by CNSVS, a computerized neurocognitive test battery; that 
is, no more improvement was seen in the treatment groups 
than in the control group. In a study of Gualtieri and Johnson34 
employing CNSVS, adults with ADHD were found to be 
impaired in measures of psychomotor speed, reaction time, 
cognitive flexibility, and attention when compared to normal 
controls. In our sample, some participants had difficulties in 
cognitive functioning measured by CNSVS, whereas some 
had no difficulties even though deficits had been reported in 
their previous neuropsychological examinations. The ceiling 
effect was also present in many participants in some of the 
tasks, especially in CPT (25 of the 29 participants received 
the maximum score of correct responses at T1) and in the 
Stroop test (26 of the 29 participants). Therefore we suggest 
that other, perhaps more sensitive, measures of cognitive 
functioning may also be needed.Neuropsychiatric Disease and Treatment 2010:6 submit your manuscript | www.dovepress.com
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Although it is not possible with this small sample to 
  predict which participants would have the most   improvement 
from CBT, we agree with Rostain and Ramsay11 that it would 
probably be those with a “more reasonable assessment of the 
treatment process and whose expectations about outcome 
were more realistic”. Our clinical impression was that the par-
ticipants who were most motivated to learn new adaptive 
skills benefited most from the CBT. Also, those who benefited 
from the CT used their training sessions as an opportunity to 
develop and test their own ideas and strategies and did not 
just “mechanically” complete the tasks.
concluding remarks
There are some limitations of the study that should be 
  considered when interpreting the results. First, the sample 
size was small in every group: 10 participants in the CBT 
group, nine participants in the CT group, and 10 in the control 
group. Thus, the results must be considered with caution. 
Second, although the participants were randomly assigned 
to either control or active treatment groups, the control group 
had no intervention during the follow-up. Therefore, possible 
  placebo effects cannot be ruled out. Even so, blinded or sham 
treatments would be almost impossible to carry out   reliably 
when studying these kinds of psychosocial   treatments. 
The third limitation is related to the severity of the ADHD 
  symptoms of the participants. In the independent evaluator’s 
CGI ratings, the participants were rated from mildly to mark-
edly ill, thus no extreme cases were included. According to 
CGI, our participants had milder ADHD than, for example, 
Rostain and Ramsay had in their study, even though our CBT 
participants’ self-ratings in the BADDS total score were 
higher.11 Thus, the independent evaluator’s personal rating 
style may have influenced the results. Also, the recruitment 
of the participants may have caused some bias towards more 
motivated and less severely disabled adults with ADHD 
participating in the study.
Despite these limitations, our study has many strengths. 
The diagnoses were made by a specialist and duly   verified, 
the outcome measures were wide-ranging (self-report 
  questionnaires, independent evaluations and neurocognitive 
testing), and we also used a control group and randomization 
in the study design. Some encouraging treatment benefits 
were obtained in the group that received short-term CBT, 
even though most of the participants were already receiving 
medication. However, CBT and CT studies with a larger 
sample size and more extensive cognitive testing are needed 
in the future. Also, the influence of treatment length and 
intensity needs to be studied.
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